UNIGE document Scientific Article
previous document  unige:112122  next document
add to browser collection

Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function

Bonaventura, Aldo
Liberale, Luca
show hidden authors show all authors [1 - 13]
Published in International journal of cardiology. 2017, vol. 231, p. 1-5
Abstract Among endocannabinoid (EC)-related mediators, Oleoyl-ethanolamide (OEA) and Palmitoyl-ethanolamide (PEA), two endogenous PPARα agonists with lipolytic and anti-inflammatory action, respectively, are being actively investigated. Here, we assessed the potential association between plasma levels of PEA and OEA and coronary function in a cohort including normal, overweight, obese, and morbidly obese (MOB) individuals.
Keywords Biomarkers/bloodBody Mass IndexChromatography, LiquidCoronary Artery Disease/blood/diagnosis/etiologyCoronary Circulation/physiologyCoronary Vessels/diagnostic imaging/physiopathologyElectrocardiographyEnzyme-Linked Immunosorbent AssayEthanolamines/bloodHumansObesity/blood/complicationsPalmitic Acids/bloodPositron Emission Tomography Computed TomographyRegional Blood Flow/physiologyVasoconstriction/physiology
PMID: 27989579
Full text
Article (Published version) (247 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Education thérapeutique du patient, diabète et obésité (600)
Toxicologie analytique et forensique (120)
(ISO format)
QUERCIOLI, Alessandra et al. Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function. In: International Journal of Cardiology, 2017, vol. 231, p. 1-5. doi: 10.1016/j.ijcard.2016.12.023 https://archive-ouverte.unige.ch/unige:112122

344 hits

0 download


Deposited on : 2018-12-07

Export document
Format :
Citation style :